Background: Despite limited data, research suggests that marijuana use is associated
impair the immune response and compromise the healing ability of the periodontal tissue, as occurs with tobacco smoking. 4 Consistent with this biologic plausibility, recent studies suggest that marijuana use may be associated with oral human papillomavirus (HPV) infection 5 and periodontitis. 6, 7 Oral HPV infection has been associated with a subset of oropharyngeal squamous cell carcinomas (OPCs), 8 being HPV-16 responsible for 87% of HPV-positive OPCs. 9 During 2011-2014, the prevalence of oral HPV infection among adults aged 18-69 years in the U. S. National Health and Nutrition Examination Survey (NHANES) was 7.3% for any type and 4.0% for oncogenic or high-risk (HR) types; men had higher prevalence of oral infection (11.5% for any HPV type and 6.8% for HR types) than women (3.3% for any type and 1.2% for HR types). 10 HPV-related OPC is increasing significantly and is expected to exceed the annual cervical cancers cases by the year 2020 in the United States. 11 Most common risk factors for oral HPV infection are male gender, high number of sexual partners, and current smoking. 12 Periodontitis is an inflammatory disease that affects the soft and hard structures that support the teeth, in which the gums pull away from the tooth and supporting gum tissues are destroyed. 13 Periodontitis has also been associated with oral cavity, oropharynx, and larynx squamous cell carcinomas. 14 During 2009-2012, prevalence of periodontitis in the United States was 46%, with 8.9% of adults aged 30 years or older having severe disease. 15 It has also been suggested that periodontitis may facilitate HPV acquisition and persistence 16 and thus may be involved in the etiology of OPCs, supporting the potential role of oral HPV infection and chronic local inflammation in OPC risk. Major common risk factors for periodontitis include age, genetics, smoking, physical inactivity, diet, and obesity. 15 Although some research studies suggest that marihuana use may be a risk factor for both oral HPV infection and severe periodontitis, results are inconclusive. Among 2009-2010 NHANES participants aged 30 to 59 years, oral HPV infection was two-fold (OR:1.92, 95%Cl: 1.07-3.44) higher in current (those who had use it at least once in the last 30 days) marihuana users than in never users. 5 However, Gillison et al. found higher prevalence of oral HPV infection in current marihuana users in crude (Prevalence Ratio = 2.87, 95% CI = 1.85-4.46), but not in multivariate analysis among adults aged 14 to 69 years. 12 Similarly, marijuana use was not independently associated with oral HPV infection in HIV-positive and HIV-negative patients with oral lesions, although marijuana use was defined as never versus ever use. 17 With respect to periodontitis, the U.S. NHANES 2011-2012 18 and a cohort study in New Zealand 6 reported positive associations between increased cannabis use (marijuana and hashish) and cannabis smoking, respectively, and periodontitis. Nonetheless, a study among young Chilean adolescents showed no association of cannabis use and periodontitis, 19 although young individuals have a lower risk of periodontitis and less likely to have had long-term exposure to cannabis. To elucidate the inconsistency in findings, additional studies assessing the association between marijuana use, oral HPV infection, and periodontitis are needed, as identification of modifiable risk factors are necessary to develop adequate preventive strategies for OPC control.
Despite the availability of various studies in this complex area, some of these are limited in sample size and lack of racial diversity, findings are somewhat inconsistent, only some have considered frequency of marijuana use, and most have not focused on marijuana use as the main exposure. [5] [6] [7] 12, [17] [18] [19] Thus, we aimed to assess if there is a positive association between marijuana use and periodontitis, and between marijuana use and oral HPV infection among a sample of Hispanic adults.
METHODS

Study design and study population
The present study analyzed data from a cross-sectional study that evaluated the association between oral HPV infection and periodontitis. The study group consisted of participants of the San Juan Overweight Adults Longitudinal Study (SOALS), which recruited overweight/obese adults aged 40-65 years in Puerto Rico between 2011 and 2013. 20, 21 The recruitment in the parent study was performed by different strategies (e.g. flyers, mass-media communications, and word of mouth). Exclusion criteria included a history of clinically diagnosed diabetes, less than four natural teeth, a history of conditions that increase the risk of systemic complications during a periodontal exam, and inability to complete study procedures. Participants were also excluded if their fasting, two-hour glucose, or HbA1c levels met the American Diabetes Association thresholds for diabetes at the baseline exam. 22 SOALS participants who came to the follow-up examination visit between September 2014 and May 2016 were invited to participate in the present study (n = 773) and 99.7% accepted to undergo the procedures. A total of 24 participants were excluded from the analysis because of incomplete HPV collection (n = 4) or periodontitis evaluation (n = 20), seven because of unsatisfactory HPV results in the laboratory (samples negative for -globin gene amplification), and five because of missing information on marijuana use; the remaining 735 (95% of recruited participants) were included in the present analysis. The study was approved by the Institutional Review Board of the University of Puerto Rico Medical Sciences Campus, and written informed consent was provided by all subjects.
Periodontitis assessment
Full mouth clinical exams were conducted using a modified version of the NHANES procedures by one examiner (JV) who had been previously trained and calibrated by the reference examiner (Dr. Bruce Dye). Periodontitis was assessed by clinical measurements of probing depth (PD) and clinical attachment loss (AL) at six sites (disto-buccal, mid-buccal, mesio-buccal, disto-lingual, mid-lingual, and mesio-lingual buccal) for all teeth, excluding the third molars. All measurements were taken with a periodontal probe (Hu-Friedy, Chicago, IL, USA, product number PCP2) and rounded off upwards to the nearest millimeter. The Centers for Disease Control/American Academy of Periodontology (CDC/AAP) working definition was used to define severe periodontitis (≥2 interproximal sites with AL ≥ 6 mm (not on the same tooth) and ≥1 interproximal site with PD ≥ 5 mm), moderate periodontitis (≥2 interproximal sites with AL ≥ 4 mm (not on the same tooth) or ≥2 interproximal sites with PD≥5 mm (not on the same tooth), and no or mild periodontitis (as neither "moderate" nor "severe" periodontitis). 23 
Collection of oral HPV specimens using oral rinse
After proper orientation by study personnel, participants self-collected oral rinse samples using the NHANES methodology 24 for HPV detection and typing; details of oral HPV collection procedures have been described in detail elsewhere. 25 A 50 mL sterile collection cup filled with 10 mL of mouthwash was given to participants. After removing any gum from their mouths, participants were asked to rinse/gargle the mouthwash for 30 seconds and spit it into the collection cup. Samples were transferred to a 15 mL tube and centrifuged at 4200 rpm for 10 min. After centrifugation, the supernatant was discarded, and the pellet was resuspended with 10 mL of saline solution [phospate buffer saline (PBS) 1 ×]. Samples were then centrifuged for a second time at 4200 rpm for 10 minutes and after discarding the supernatant, the remaining pellet was resuspended with 1 mL of saline solution (PBS 1 ×). The resuspended whole pellet was then transferred to a preidentified 2.0 mL micro-tube and stored at -80 • C until shipment to the HPV Virology Core Laboratory at the University of California in San Francisco.
DNA extraction/HPV detection and typing
HPV typing was performed at UCSF using polymerase chain reaction (PCR) with modified L1 consensus primers (MY09/MY11). After thawing, the samples were processed for DNA using the Gentra Puregene Buccal Cell Kit (QIA-GEN) following manufacturer's instructions. Five microliters of sample were used for PCR amplification using the standard 40 cycle protocol 26 ; PCR is a highly sensitive method for the detection of HPV DNA. 27 
Assessment of marijuana use
Participants completed an audio computer-assisted selfinterview to gather information on drug use. Marijuana use was defined as no use (never/once in lifetime), occasional use, and frequent use. Frequent marijuana use was defined as having consumed marijuana ≥ 26 times during the lifetime, ≥ 6 times during the past year, and ≥2 times during the past 30 days; the remaining participants were classified as occasional users.
Assessment of potential confounders
Demographic, clinical, and behavioral characteristics were collected by the parent study using face-to-face interviews, and sexual behaviors were collected using an audio computerassisted self-interview. These variables were collected given their relevance as risk factors for oral HPV infection 12 and/or periodontitis. 15 Covariates included gender (male, female), age (41-54, ≥55 years), education (≤12, > 12 years), income (< $20,000, ≥$20,000), and health insurance (private, public, none). Clinical characteristics included obesity [obese if body mass index (BMI) ≥30 kg/m 2 , nonobese if BMI < 30 kg/m 2 ], 30 abdominal obesity (at risk if waist circumference in men > 102 cm and if waist circumference in women > 88 cm, not at risk if below these thresholds), 30 impaired glucose metabolism (fasting glucose ≥100 mg/dl, 2-hour post load glucose ≥ 140 mg/dl, or HbA1c ≥ 5.7%), 22 dental visits in the past three years (yes, no), and periodontal treatment in the past three years (yes, no). Behavioral characteristics included current smoking (yes/no), binge drinking (5 or more drinks on a single occasion for men or 4 or more drinks on a single occasion for women in the last 30 days), and lifetime number of oral sex partners (0-5, ≥6).
Statistical analysis
Frequency distributions were used to describe sociodemographic, clinical, and behavioral characteristics of study participants. Contingency tables, chi-square statistics, and Fisher's exact test were used to describe the associations of marijuana use and other covariates with oral HPV infection and periodontitis severity. Separate multivariable logistic regression models were fitted to evaluate the associations of marijuana use with oral HPV infection and severe periodontitis. The models were adjusted by covariates significantly associated (p < 0.05) in the bivariate analysis to both oral HPV infection and periodontitis and other relevant variables in the literature. The statistical package Stata for Windows, version 14 (Stata Corporation, College Station, TX) was used for data management and statistical analyses.
RESULTS
Univariate analysis
Mean age of participants was 53.4 ±6.6 years, 72.4% were women, and 18.4% were current smokers (Table 1) . Overall, 26.5% of study participants had ever consumed marijuana during their lifetime and 10.1% had consumed it on at least 26 occasions. Less than 10% reported marijuana use at least twice (7.1%) during the past 12 months and past 30 days (3.9%) (data not shown). Overall, 2.7% were frequent marijuana users, and 5.7% of persons had oral HPV infection. According to the CDC/APP definition, 23 39 .5% had moderate periodontitis and 20.1% had severe periodontitis (Table 1) .
Bivariate analyses
Although age was not associated with oral HPV infection in bivariate analysis, men (10.3%) had higher prevalence of oral HPV infection compared to women (3.9%) (p = 0.001), as well as did persons with no health care coverage (12.7%) compared to those with private (4.1%) and public (6.6%) health insurance (p = 0.026) ( Table 2 ). Prevalence of oral HPV infection was also higher among persons with severe periodontitis (11.5%) compared to those with moderate (4.1%) or none/mild (4.4%) disease (p = 0.003). Among lifestyle characteristics, persons with at least six lifetime number of oral sex partners had higher prevalence of oral HPV infection (12.3%) compared to their counterparts (4.0%) (p < 0.001). Meanwhile, the prevalence of oral HPV infection increased from 4.1% among nonusers to 10.2% and 10.0% among occasional and frequent marihuana users, respectively (p = 0.006).
For periodontitis, men had higher prevalence of moderate (45.6% versus 37.1%) and severe (30.4% versus 16.2%) periodontitis compared to women (p < 0.001) ( Table 2) . Adults in the older age group also had higher prevalence of moderate and mild periodontitis than their counterparts (p < 0.001). Lower education and lower annual income were also positively associated with severity of periodontitis (p < 0.05). Participants without health insurance (29.1%) and with public health insurance (27.2%) had higher prevalence of severe periodontitis than persons with private health care coverage (13.6%) (p < 0.001). The prevalence of severe periodontitis was also higher in persons with oral HPV infection (40.5%) than in those without infection (18.9%). Current smoking, binge drinking and having ≥6 lifetime number of oral sex partners were all positively associated with periodontitis severity in bivariate analyses (p < 0.05). Finally, the prevalence of severe periodontitis increased from 17.0% among nonmarihuana users, to 25.7% in occasional users, to 55.0% among frequent users (p < 0.001).
Multivariable analysis
Although occasional marijuana users were more likely to have oral HPV infection compared to nonusers in bivariate analysis, no significant association was observed between marijuana use and oral HPV infection in multivariable analysis adjusting for sex, age, healthcare coverage, oral sex partners and periodontitis (Table 3) . On the other hand, occasional (OR = 1.69, 95% CI = 1.12-2.53) and frequent (OR = 5.95, 95% CI = 2.40-14.77) marihuana users had significantly increased odds of severe periodontitis. However, only frequent marijuana users had increased odds of periodontitis (OR = 2.93, 95% CI = 1.08-7.96) compared to nonusers after adjusting for sex, age, healthcare coverage, current smoke, binge drinking, oral sex partners, oral HPV infection, and dental visits (Table 3) .
DISCUSSION
This study evaluated the association of marijuana use with oral HPV infection and periodontitis in a Hispanic adult population. Overall, 5.7% of the study population had oral HPV infection, 20.1% had severe periodontitis, 23.8% were occasional marihuana users, and 2.7% were frequent users. Our results evidenced an association between marijuana use and severe periodontitis, but not with oral HPV infection. The lack of statistical association between marijuana use and oral HPV infection in multivariable models adjusting for HPV risk factors, including gender and number of oral sex partners, 12 highlights the relevance of these other known risk factors, rather than marijuana consumption, on oral HPV infection. Although our definition of marijuana consumption is limited in its determination of frequency of use throughout the life course, which may have an impact on study findings, our study result is consistent with other previous studies. A study of young adults aged 19-35 years that evaluates ever illegal drug use, including cannabis, 31 in which the authors suggested that the absence of a statistically significant association may be attributed to the low prevalence of oral HPV infection in the study sample (4.0%) and lack of statistical power. Two previous studies in Puerto Rico did not find an association between marijuana use and oral HPV infection among drug users 32 and men from an STI clinic, 33 although frequency of marijuana use was not assessed in these analyses. However, the analysis performed in adults aged 30 to 59 years using the 2009-2010 NHANES data found that current marijuana use was independently associated with oral HPV infection. 5 Similarly, a hospital-based case-control study reported an association between oral HPV-16 infection and current marijuana use (OR = 4.7, 95% Cl: 1.3-17.0) 34 among patients diagnosed with HPV-16 -positive head and neck squamous cell carcinomas. According to the CDC/APP definition, 23 39.5% of study participants had moderate periodontitis and 20.1% had severe periodontitis. Meanwhile, a strong association (close to 3-fold) between frequent marijuana use and severe periodontitis was evidenced, even after adjusting for various confounders, including tobacco, age, and other periodontitis risk factors. This result is consistent with the NHANES 2011-2012 cross-sectional study (n = 1938) among adults in which the authors reported that frequent users of cannabis (marihuana and hashish) at least once per month for the last 12 months had higher odds of having severe periodontitis in comparison to their counterparts. 18 Similarly, a prospective cohort study in New Zealand 6 found that young individuals in the some exposure of cannabis group (RR = 1.47, 95%Cl: 0.87-2.47) and in the high exposure group (> 40 times, RR = 2.15, 95%CI: 1.20-3.85) had increased risk of periodontitis compared to those in the no exposure group, independent of tobacco consumption. 6 The mechanism in which the use of marijuana affects the risk of HPV is unclear. It is known that the virus can lodge in the surface of the mouth, the linings of the lips or the tongue. 35 A possible route of transmission for HPV can be through sharing a rolled cigarette or pipe in a group setting. 35 Meanwhile, various mechanisms have been proposed for the potential link between marijuana and periodontitis. First of all, it is known that cannabis users have lesser oral health than the general population, including less healthy gingiva. 36, 37 Some of the acute symptoms that cause the marijuana use in the mouth are irritation of the oral epithelium, which is one of the symptoms of periodontal disease. Additionally, chronic use of marijuana may produce a chronic inflammation of the oral epithelium, which can progress to neoplasia. 36 In addition, THC, the most potent cannabinoid in cannabis, has an immunosuppressive effect through the cannabinoid receptor type 2 found in immune cells. 38 THC can potentially propagate change of oral microbiota altering the immune response. 38 Gingival enlargement occurs mainly in the marginal and papillary part of the mouth, 39 possibly because of smoke accumulation. 39 Research has also found that frequent marijuana use could lead to cytokine suppression in periodontitis, supporting the potential local immunosuppressant role of marijuana use. 40 In addition, animal models have shown that marijuana smoke may affect alveolar bone by increasing bone loss in rats with ligature-induced periodontitis. 41 Further research of the biologic mechanisms of this association are warranted. Given the increased acceptance and legalization of marijuana use worldwide, further understanding of its beneficial therapeutic and detrimental effects on human health is of great relevance. In fact, researchers have suggested that changing patterns of marijuana legalization world-wide have led to a need to conduct further studies assessing the association between marijuana use and cancer risk. 42 With respect to oropharyngeal cancer, marijuana use has been reported as a potential risk factor for this malignancy. 43 Although our results did not evidence an association between marijuana use and oral HPV infection, a strong association was observed between marijuana use and periodontitis. Given that periodontitis has been suggested as a potential risk factor for oropharyngeal cancer, 40, 43 our study results may have implications for oral cancer prevention, as marijuana users may need periodontitis screening and treatment as a way to prevent oral cancer risk among them. Thus, longitudinal wellpowered studies on these associations are warranted to better conclude on the links and potential interactions of these risk factors (marijuana use, periodontal disease, and oral HPV infection) with oropharyngeal cancer risk.
Our study has several limitations. First, marijuana use and frequency was based on self-report, which is often underreported and subject to recall bias. Marijuana was defined in terms of frequency of use, but we did not collect amount of marijuana consumed, route of consumption (inhaled versus oral), and duration of use and time when they quit. Also, a temporal association between marijuana use and periodontal disease and oral HPV infection could not be established because of the cross-sectional nature of the study. Also, the low prevalence of frequent marijuana use and oral HPV infection limited the statistical power of this study to detect a significant association between marijuana use and oral HPV infection. In addition, given that many marijuana users were ever smokers, analysis of the association among never smokers was not performed because of the limited sample size. Finally, the lack of uniformity in defining marihuana use across studies may lead to conflicting results and limits comparability of study findings.
CONCLUSION
Despite these limitations, we conclude that marijuana use was strongly associated with severe periodontitis in this Hispanic adult population, but not to oral HPV infection. Further evaluation of the role of frequent marijuana use in oral HPV infection and periodontitis, as well as on the interaction of these factors on OPC risk, may inform novel preventive public health strategies, as marijuana users could be a potential target for oral health screening and intervention efforts. 38 
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